GnT-V, the enzyme responsible for the synthesis of β1,6-branched N-glycans, is commonly upregulated in CRC correlating to the metastatic potential and consequently considered an important prognosis factor to detect poor CRC patients’ outcome (41). The gene discussed is MGAT5; the disease is colorectal carcinoma.